"With the U.S. government set to issue new dietary guidelines for Americans in January," food industry groups and PR firms are preparing to capitalize on the recommendations, writes PR Week. Burson-Marsteller's U.S.

Concerns about the safety of Pfizer's Celebrex, Merck's Vioxx and other so-called COX-2 inhibitor drugs represent "perhaps the clearest instance yet of how the confluence of medicine and marketing can turn hope into hype - and how difficult it is for the Food and Drug Administration to monitor the safety of drugs after they have been approved f

"While the forestry industry in [the Australian state of] Tasmania is notoriously defensive, Gunns appears to be setting new standards," reports the Independent.